Skip to Main Content


Skip Nav Destination
Issue Cover
Current Issue
Volume 13,
Issue 3
1 March 2023

About the Journal

Cancer Discovery publishes high-impact articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to epidemiologic studies. The journal also publishes News and Research Watch sections.Read More About the Journal

Noted This Week

Novartis announced that the FDA approved dabrafenib (Tafinlar) with trametinib (Mekinist) for children age 1 and older with low-grade glioma with a BRAFV600E mutation. The agency also OK’d new oral formulations of both drugs for patients who cannot swallow pills. This is the first approval of a systemic therapy as an initial treatment for children with this condition.

More Noted This Week, March 10–16   »

Close Modal

or Create an Account

Close Modal
Close Modal